Gefitinib Tablets 250 mg

Gefitinib Tablets 250 mg  is indicated as monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies who are benefiting or have benefited from Gefitinib .

It is manufactured by many Indian manufacturers including Brands like Natco Pharma Ltd.

3S corporation is Supplier,Exporter,Wholesaler for Gefitinib Tablets 250 mg in India.

The recommended daily dose of Gefitinib  is one 250 mg tablet with or without food. Higher doses do not give a better response and cause increased toxicity.

Gefitinib Tablets 250 mg tablets can also be dispersed in half a glass of drinking water (noncarbonated). No other liquids should be used

• an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
• lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
• severe or persistent nausea, vomiting, loss of appetite, or diarrhea;